Clinical Trial Update: Compassionate Use of Eribulin for the Treatment of Advanced Breast Cancer Refractory to All Other Marketed Therapies [NA]

View source ↗

Summary

This document reports the completion of a compassionate-use clinical trial of eribulin for advanced breast cancer refractory to all other marketed therapies, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Eribulin (eribulin mesilate)

Snippet

Sponsor: Eisai Inc. | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2013-09-20